Technology
Nelnet Reports First Quarter 2025 Results
Published
12 months agoon
By
LINCOLN, Neb., May 8, 2025 /PRNewswire/ — Nelnet (NYSE: NNI) today reported GAAP net income of $82.6 million, or $2.26 per share, for the first quarter of 2025, compared with GAAP net income of $73.4 million, or $1.98 per share, for the same period a year ago.
Net income, excluding derivative market value adjustments1, was $87.4 million, or $2.39 per share, for the first quarter of 2025, compared with $67.4 million, or $1.81 per share, for the same period in 2024.
“We’re pleased with Nelnet’s strong operating results to kick off 2025,” said Jeff Noordhoek, chief executive officer of Nelnet. “In a challenging and uncertain economic environment, all our core businesses are performing well and contributing to this momentum. We enhanced our already strong capital and liquidity positions, allowing us to be ready to strategically invest in opportunities that we believe will drive long-term success and value creation.”
Nelnet has four reportable operating segments, earning interest income on loans in its Asset Generation and Management (AGM) and Nelnet Bank segments, both part of the company’s Nelnet Financial Services (NFS) division, and fee-based revenue in its Loan Servicing and Systems (referred to as Nelnet Diversified Services (NDS)) and Education Technology Services and Payments (referred to as Nelnet Business Services (NBS)) segments. Other business activities and operating segments that are not reportable and not part of the NFS division are combined and included in Corporate Activities.
Asset Generation and Management
The AGM operating segment reported loan and investment net interest income of $52.9 million during the first quarter of 2025, compared with $40.6 million for the same period a year ago. The increase in 2025 was due to an increase in loan spread2, but was partially offset by the expected runoff of the Federal Family Education Loan Program (FFELP) loan portfolio. The average balance of loans outstanding decreased from $11.6 billion for the first quarter of 2024 to $9.5 billion for the same period in 2025.
AGM recognized a provision for loan losses in the first quarter of 2025 of $13.0 million ($9.9 million after tax), compared with $6.5 million ($4.9 million after tax) in the first quarter of 2024. Provision for loan losses was primarily impacted by establishing an initial allowance for loans acquired during the period. During the first quarter of 2025, AGM acquired $832.6 million of loans, including $702.8 million of FFELP loans.
In addition, AGM recognized a loss of $3.8 million ($2.9 million after tax) related to changes in the fair value of derivative instruments that do not qualify for hedge accounting, compared with income of $5.7 million ($4.3 million after tax) for the same period in 2024. AGM recognized net income after tax of $22.7 million for the three months ended March 31, 2025, compared with $25.6 million for the same period in 2024.
1
Net income, excluding derivative market value adjustments, is a non-GAAP measure. See “Non-GAAP Performance Measures” at the end of this press release and the “Non-GAAP Disclosures” section below for explanatory information and reconciliations of GAAP to non-GAAP financial information.
2
Loan spread represents the spread between the yield earned on loan assets and the costs of the liabilities and derivative instruments used to fund the assets.
Nelnet Bank
As of March 31, 2025, Nelnet Bank had a $761.6 million and $872.2 million loan and investment portfolio, respectively, and total deposits, including intercompany deposits, of $1.38 billion. Nelnet Bank reported loan and investment net interest income of $12.4 million during the first quarter of 2025, compared with $7.6 million for the same period a year ago. The increase in 2025 was due to an increase in the loan and investment portfolio and net interest margin.
Nelnet Bank recognized a provision for loan losses in the first quarter of 2025 of $2.3 million ($1.7 million after tax), compared with $4.4 million ($3.3 million after tax) in the first quarter of 2024. In addition, Nelnet Bank recognized a loss of $2.5 million ($1.9 million after tax) related to changes in the fair value of derivative instruments that do not qualify for hedge accounting, compared with income of $2.3 million ($1.7 million after tax) for the same period in 2024.
Nelnet Bank recognized net income after tax for the quarter ended March 31, 2025 of $1.5 million, compared with $0.9 million for the same period in 2024.
Loan Servicing and Systems
Revenue from the Loan Servicing and Systems segment was $120.7 million for the first quarter of 2025, compared with $127.2 million for the same period in 2024. On April 1, 2024, the company began to earn revenue under its new Unified Servicing and Data Solution (USDS) contract which replaced its legacy student loan servicing contract with the Department of Education (Department). Revenue earned under the USDS contract on a per borrower blended basis is lower than the legacy contract. The decrease in revenue from the government servicing contract was partially offset by an increase in private education loan servicing revenue. Private and consumer loan servicing revenue increased to $22.7 million for the three months ended March 31, 2025, compared with $12.6 million for the same period in 2024, as a result of the conversion of Discover Financial Services and SoFi Lending Corp. loan portfolios during the fourth quarter of 2024 and first quarter of 2025.
As of March 31, 2025, the company was servicing $542.3 billion in government-owned, FFELP, private education, and consumer loans for 15.6 million borrowers, compared with $532.2 billion in servicing volume for 15.9 million borrowers as of March 31, 2024.
The Loan Servicing and Systems segment reported net income after tax of $14.1 million for the three months ended March 31, 2025, compared with $12.2 million for the same period in 2024.
Education Technology Services and Payments
For the first quarter of 2025, revenue from the Education Technology Services and Payments operating segment was $147.3 million, an increase from $143.5 million for the same period in 2024. Revenue less direct costs to provide services for the first quarter of 2025 was $99.3 million, compared with $94.9 million for the same period in 2024.
Net income after tax for the Education Technology Services and Payments segment was $36.1 million for the three months ended March 31, 2025, compared with $36.2 million for the same period in 2024.
This segment is subject to seasonal fluctuations. Based on the timing of when revenue is recognized and when expenses are incurred, revenue and operating margin are higher in the first quarter compared with the remainder of the year.
Corporate Activities
Included in Corporate Activities are the operating results of the company’s 45 percent voting membership interest in ALLO Holdings LLC, a holding company for ALLO Communications LLC (ALLO). During the first quarter of 2024, the company recognized a loss on its ALLO voting membership interest investment of $10.7 million ($8.1 million after tax). The company has no remaining carrying value related to this investment in ALLO. Accordingly, no losses were recognized on this investment in the first quarter of 2025, and absent additional voting membership equity contributions, the company will not recognize future losses on this investment.
As previously announced in April 2025, Nelnet entered into an agreement with ALLO pursuant to which ALLO will redeem certain of its membership interests from Nelnet. Upon closing, Nelnet expects to receive aggregate cash proceeds of approximately $410 million from ALLO for these redemptions and recognize a pre-tax gain of approximately $175 million. The transaction is expected to close in late May 2025, subject to customary closing conditions. Immediately following the closing of the transaction, Nelnet will not own any preferred membership interests of ALLO, but will maintain a significant voting equity investment in ALLO. Nelnet’s ownership of ALLO will decrease from 45% to approximately 26%.
Board of Directors Declares Second Quarter Dividend and Authorizes New Stock Repurchase Program
The Nelnet Board of Directors declared a second-quarter cash dividend on the company’s outstanding shares of Class A common stock and Class B common stock of $0.28 per share. The dividend will be paid on June 16, 2025, to shareholders of record at the close of business on June 2, 2025.
In addition, the Board of Directors has authorized a new stock repurchase program to purchase up to five million shares of the company’s Class A common stock during the three-year period ending May 8, 2028. The five million shares authorized under the new program includes the remaining unpurchased shares from the prior repurchase program, which expires on May 8, 2025. Shares may be repurchased under the new program from time to time in the open market or private transactions (including with related parties), and the timing and amount of repurchases will depend on market conditions, share prices, trading volumes, and other factors, including compliance with credit agreements and securities laws.
Forward-Looking and Cautionary Statements
This press release contains forward-looking statements within the meaning of federal securities laws. The words “anticipate,” “assume,” “believe,” “continue,” “could,” “ensure,” “estimate,” “expect,” “forecast,” “future,” “intend,” “may,” “plan,” “potential,” “predict,” “scheduled,” “should,” “will,” “would,” and similar expressions, as well as statements in future tense, are intended to identify forward-looking statements. These statements are based on management’s current expectations as of the date of this release and are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results and performance to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: risks related to the ability to successfully maintain and increase allocated volumes of student loans serviced by the company under existing and future servicing contracts with the Department, risks related to unfavorable contract modifications or interpretations, risks related to consistently meeting service requirements to avoid the assessment of performance penalties, and risks related to the company’s ability to comply with agreements with third-party customers for the servicing of Federal Direct Loan Program, FFEL Program, private education, and consumer loans; loan portfolio risks such as credit risk, prepayment risk, interest rate basis and repricing risk, risks related to the use of derivatives to manage exposure to interest rate fluctuations, uncertainties regarding the expected benefits from purchased securitized and unsecuritized FFELP, private education, consumer, and other loans, or investment interests therein, and initiatives to purchase additional FFELP, private education, consumer, and other loans; financing and liquidity risks, including risks of changes in the interest rate environment; risks from changes in the terms of education loans and in the educational credit and services markets resulting from changes in applicable laws, regulations, and government programs and budgets; risks related to a breach of or failure in the company’s operational or information systems or infrastructure, or those of third-party vendors, including disclosure of confidential or personal information and/or damage to reputation resulting from cyber breaches; risks related to use of artificial intelligence; uncertainties inherent in forecasting future cash flows from student loan assets, including investment interests therein, and related asset-backed securitizations; risks related to the ability of Nelnet Bank to achieve its business objectives and effectively deploy loan and deposit strategies and achieve expected market penetration; risks related to the expected benefits to the company from its continuing investment in ALLO and Hudl, and risks related to solar tax equity investments, including risks of not being able to realize tax credits which remain subject to recapture by taxing authorities; risks and uncertainties related to other initiatives to pursue additional strategic investments (and anticipated income therefrom) including venture capital and real estate investments, reinsurance, acquisitions, solar construction, and other activities (including risks associated with errors that occasionally occur in converting loan servicing portfolios to a new servicing platform), including activities that are intended to diversify the company both within and outside of its historical core education-related businesses; risks and uncertainties associated with climate change; risks from changes in economic conditions and consumer behavior; risks related to the company’s ability to adapt to technological change; risks related to the exclusive forum provisions in the company’s articles of incorporation; risks related to the company’s executive chairman’s ability to control matters related to the company through voting rights; risks related to related party transactions; risks related to natural disasters, terrorist activities, or international hostilities; and risks and uncertainties associated with litigation matters and maintaining compliance with the extensive regulatory requirements applicable to the company’s businesses, including changes to the regulatory environment from the change in presidential administration, and uncertainties inherent in the estimates and assumptions about future events that management is required to make in the preparation of the company’s consolidated financial statements.
For more information, see the “Risk Factors” sections and other cautionary discussions of risks and uncertainties included in documents filed or furnished by the company with the Securities and Exchange Commission. All forward-looking statements in this release are as of the date of this release. Although the company may voluntarily update or revise its forward-looking statements from time to time to reflect actual results or changes in the company’s expectations, the company disclaims any commitment to do so except as required by law.
Non-GAAP Performance Measures
The company prepares its financial statements and presents its financial results in accordance with U.S. GAAP. However, it also provides additional non-GAAP financial information related to specific items management believes to be important in the evaluation of its operating results and performance. Reconciliations of GAAP to non-GAAP financial information, and a discussion of why the company believes providing this additional information is useful to investors, is provided in the “Non-GAAP Disclosures” section below.
Consolidated Statements of Income
(Dollars in thousands, except share data)
(unaudited)
Three months ended
March 31, 2025
December 31, 2024
March 31, 2024
(1)
Interest income:
Loan interest
$ 166,439
178,434
216,724
Investment interest
41,389
42,815
52,078
Total interest income
207,828
221,249
268,802
Interest expense on bonds and notes payable and bank deposits
125,114
141,170
194,580
Net interest income
82,714
80,079
74,222
Less provision for loan losses
15,337
22,057
10,828
Net interest income after provision for loan losses
67,377
58,022
63,394
Other income (expense):
Loan servicing and systems revenue
120,741
137,981
127,201
Education technology services and payments revenue
147,330
108,335
143,539
Reinsurance premiums earned
24,687
18,673
12,780
Solar construction revenue
3,995
13,828
13,726
Other, net
23,694
27,794
4,082
Gain (loss) on sale of loans, net
909
42
(141)
Derivative market value adjustments and derivative settlements, net
(5,578)
14,879
9,721
Total other income (expense), net
315,778
321,532
310,908
Cost of services and expenses:
Loan servicing contract fulfillment and acquisition costs
1,633
1,497
—
Cost to provide education technology services and payments
48,047
38,658
48,610
Cost to provide solar construction services
7,828
28,558
14,229
Total cost of services
57,508
68,713
62,839
Salaries and benefits
138,223
147,229
143,875
Depreciation and amortization
9,255
12,544
16,769
Reinsurance losses and underwriting expenses
22,212
16,180
11,317
Other expenses
48,226
50,681
45,528
Total operating expenses
217,916
226,634
217,489
Impairment expense and provision for beneficial interests
1,591
5,764
37
Total expenses
277,015
301,111
280,365
Income before income taxes
106,140
78,443
93,937
Income tax expense
(25,010)
(15,016)
(23,181)
Net income
81,130
63,427
70,756
Net loss (gain) attributable to noncontrolling interests
1,430
(268)
2,652
Net income attributable to Nelnet, Inc.
$ 82,560
63,159
73,408
Earnings per common share:
Net income attributable to Nelnet, Inc. shareholders – basic and diluted
$ 2.26
1.73
1.98
Weighted average common shares outstanding – basic and diluted
36,478,426
36,461,513
37,156,971
(1)
During the second quarter of 2024, the company identified certain immaterial errors in the previously issued consolidated financial statements that have been corrected to conform to the March 31, 2025 presentation. Refer to the company’s quarterly report on Form 10-Q for the three months ended March 31, 2025 that was filed with the Securities and Exchange Commission on May 8, 2025 for additional information.
Condensed Consolidated Balance Sheets
(Dollars in thousands)
(unaudited)
As of
As of
As of
March 31, 2025
December 31, 2024
March 31, 2024
(1)
Assets:
Loans and accrued interest receivable, net
$ 10,422,704
9,992,744
11,829,078
Cash, cash equivalents, and investments
2,523,067
2,395,214
2,112,999
Restricted cash
611,610
736,502
761,141
Goodwill and intangible assets, net
192,832
194,357
200,699
Other assets
441,745
458,936
470,295
Total assets
$ 14,191,958
13,777,753
15,374,212
Liabilities:
Bonds and notes payable
$ 8,656,157
8,309,797
10,582,513
Bank deposits
1,313,407
1,186,131
802,061
Other liabilities
859,385
982,708
753,918
Total liabilities
10,828,949
10,478,636
12,138,492
Equity:
Total Nelnet, Inc. shareholders’ equity
3,419,523
3,349,762
3,297,190
Noncontrolling interests
(56,514)
(50,645)
(61,470)
Total equity
3,363,009
3,299,117
3,235,720
Total liabilities and equity
$ 14,191,958
13,777,753
15,374,212
(1)
During the second quarter of 2024, the company identified certain immaterial errors in the previously issued consolidated financial statements that have been corrected to conform to the March 31, 2025 presentation. Refer to the company’s quarterly report on Form 10-Q for the three months ended March 31, 2025 that was filed with the Securities and Exchange Commission on May 8, 2025 for additional information.
Non-GAAP Disclosures
(Dollars in thousands, except share data)
(unaudited)
Non-GAAP financial measures disclosed by management are meant to provide additional information and insight relative to business trends to investors and, in certain cases, to present financial information as measured by rating agencies and other users of financial information. These measures are not in accordance with, or a substitute for, GAAP and may be different from, or inconsistent with, non-GAAP financial measures used by other companies. The company reports this non-GAAP information because the company believes that it provides additional information regarding operational and performance indicators that are closely assessed by management. There is no comprehensive, authoritative guidance for the presentation of such non-GAAP information, which is only meant to supplement GAAP results by providing additional information that management utilizes to assess performance.
Net income, excluding derivative market value adjustments
Three months ended March 31,
2025
2024
GAAP net income attributable to Nelnet, Inc.
$ 82,560
73,408
Realized and unrealized derivative market value adjustments (a)
6,324
(7,964)
Tax effect (b)
(1,519)
1,911
Non-GAAP net income attributable to Nelnet, Inc., excluding derivative market
value adjustments
$ 87,365
67,355
Earnings per share:
GAAP net income attributable to Nelnet, Inc.
$ 2.26
1.98
Realized and unrealized derivative market value adjustments (a)
0.17
(0.22)
Tax effect (b)
(0.04)
0.05
Non-GAAP net income attributable to Nelnet, Inc., excluding derivative market
value adjustments
$ 2.39
1.81
(a)
“Derivative market value adjustments” includes both the realized portion of gains and losses (corresponding to variation margin received or paid on derivative instruments that are settled daily at a central clearinghouse) and the unrealized portion of gains and losses that are caused by changes in fair values of derivatives which do not qualify for “hedge treatment” under GAAP. “Derivative market value adjustments” does not include “derivative settlements” that represent the cash paid or received during the current period to settle with derivative instrument counterparties the economic effect of the company’s derivative instruments based on their contractual terms.
The accounting for derivatives requires that changes in the fair value of derivative instruments be recognized currently in earnings, with no fair value adjustment of the hedged item, unless specific hedge accounting criteria are met. Management has structured all of the company’s derivative transactions with the intent that each is economically effective; however, the company’s derivative instruments do not qualify for hedge accounting in the consolidated financial statements. As a result, the change in fair value of derivative instruments is reported in current period earnings with no consideration for the corresponding change in fair value of the hedged item. Under GAAP, the cumulative net realized and unrealized gain or loss caused by changes in fair values of derivatives in which the company plans to hold to maturity will equal zero over the life of the contract. However, the net realized and unrealized gain or loss during any given reporting period fluctuates significantly from period to period.
The company believes these point-in-time estimates of asset and liability values related to its derivative instruments that are subject to interest rate fluctuations are subject to volatility mostly due to timing and market factors beyond the control of management, and affect the period-to-period comparability of the results of operations. Accordingly, the company’s management utilizes operating results excluding these items for comparability purposes when making decisions regarding the company’s performance and in presentations with credit rating agencies, lenders, and investors
(b)
The tax effects are calculated by multiplying the realized and unrealized derivative market value adjustments by the applicable statutory income tax rate.
View original content:https://www.prnewswire.com/news-releases/nelnet-reports-first-quarter-2025-results-302450504.html
SOURCE Nelnet, Inc.
You may like
Technology
Weibo Corporation to Report First Quarter 2026 Financial Results on May 28, 2026
Published
7 minutes agoon
April 27, 2026By
BEIJING, April 27, 2026 /PRNewswire/ — Weibo Corporation (NASDAQ: WB and HKEX: 9898), a leading social media for people to create, share and discover content, will announce its unaudited financial results for the first quarter 2026 before the U.S. market opens on Thursday, May 28, 2026. Following the announcement, Weibo’s management team will host a conference call from 7 AM – 8 AM Eastern Time on May 28, 2026 (or 7 PM – 8 PM Beijing Time on May 28, 2026) to present an overview of the Company’s financial performance and business operations.
Participants who wish to dial in to the teleconference must register through the below public participant link. Dial in and instruction will be in the confirmation email upon registering.
Participants Registration Link: https://register-conf.media-server.com/register/BIb549b1f6935046d98b52a0fe61be918e
Additionally, a live and archived webcast of this conference call will be available at http://ir.weibo.com.
About Weibo Corporation
Weibo is a leading social media for people to create, share and discover content online. Weibo combines the means of public self-expression in real time with a powerful platform for social interaction, content aggregation and content distribution. Any user can create and post a feed and attach multi-media and long-form content. User relationships on Weibo may be asymmetric; any user can follow any other user and add comments to a feed while reposting. This simple, asymmetric and distributed nature of Weibo allows an original feed to become a live viral conversation stream.
Weibo enables its advertising and marketing customers to promote their brands, products and services to users. Weibo offers a wide range of advertising and marketing solutions to companies of all sizes. The Company generates a substantial majority of its revenues from the sale of advertising and marketing services, including the sale of social display advertisement and promoted marketing offerings. Designed with a “mobile first” philosophy, Weibo displays content in a simple information feed format and offers native advertisement that conform to the information feed on our platform. To support the mobile format, we have developed and continuously refining our social interest graph recommendation engine, which enables our customers to perform people marketing and target audiences based on user demographics, social relationships, interests and behaviors, to achieve greater relevance, engagement and marketing effectiveness
Contact:
Investor Relations
Weibo Corporation
Phone: +86 10 5898-3336
Email: ir@staff.weibo.com
View original content:https://www.prnewswire.com/news-releases/weibo-corporation-to-report-first-quarter-2026-financial-results-on-may-28-2026-302754018.html
SOURCE Weibo Corporation
Technology
Perceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with Trialzen
Published
7 minutes agoon
April 27, 2026By
Expert-led clinical supply strategy powered by advanced planning and analytics technologies.
NOTTINGHAM, England and LASNE, Belgium, April 27, 2026 /PRNewswire/ — Perceptive eClinical, a leading provider of interactive response technology (IRT) and eClinical solutions, and Trialzen, an expert-led Forecasting and Supply Technology company, today announced an alliance supporting Perceptive eClinical in the launch of its Clinical Intelligence Consultancy Service, Perceptive Clinical Intelligence. This transforms its long–standing clinical supply expertise into a fully integrated, expert–led service spanning the entire clinical trial lifecycle and enabled by Trialzen’s advanced clinical supply planning technologies.
Perceptive Clinical Intelligence combines Perceptive’s deep expertise in randomization and clinical supply optimization with data-driven, technology enabled mathematical optimization, simulation, and forecasting to support smarter planning across the trial lifecycle. This integrated offering helps sponsors design, stress test, and manage clinical supply strategies with greater confidence and operational control. By formalizing its in-house expertise and therapeutic experience, Perceptive unifies randomization, trial supply management technologies and clinical supply consulting to enable more informed, scalable, and lower risk supply decision making.
“Clinical trial supply decisions are too critical to rely on tools alone,” said Malcolm Morrissey, Head of Perceptive Clinical Intelligence. “While supply discussions often focus on stock levels and overage, the real risk is patient impact. Supply availability determines whether visits happen, treatment is delivered on time, and sites can operate with confidence. Effective supply management means looking beyond IP numbers to understand patient continuity and visit level risk across the entire trial.”
Industry benchmarks show that approximately 50% of Clinical Finished Goods (CFG) manufactured for clinical trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply each year1.
“Setting up Perceptive Clinical Intelligence reflects the next step in Perceptive’s evolution, combining deep clinical supply and randomization expertise with data–driven technology to enable smarter supply planning, and increased supply confidence, and continuity across the trial lifecycle,” said Shaun Hopgood, Chief Operating Officer at Perceptive eClinical.
Perceptive eClinical and Trialzen have each delivered proven results for sponsors, with real–world engagements generating savings exceeding $1 million and materially reducing supply overage.
A Technology Enabled, Expert-Led Approach
Delivered by Perceptive’s in–house specialists, the consultancy is built on 30 years of experience supporting biotech and large pharma across randomization and clinical supply management. It combines Perceptive’s proven supply–modelling expertise with Trialzen’s advanced calculation and simulation engine, fully integrated into Perceptive’s next–generation platform, Clinphone Pro.
Anchored in deep oncology expertise, where global scale, complex dosing, and multi–layered supply chains increase planning risk, the consultancy also draws on experience across Endocrinology and Metabolism, and Infectious Diseases, and supports emerging areas such as Precision and Nuclear Medicine, and Cell and Gene Therapies.
Reflecting on this alliance and its objectives, Cedric Druck, CEO and Co–Founder of Trialzen, commented: “Trialzen was built by clinical supply experts who spent years watching planning decisions get made on spreadsheets and gut feel, then handed off to execution systems with no feedback loop. This collaboration with Perceptive closes that gap. By integrating our forecasting and simulation capabilities directly with their IRT platform, we enable sponsors to move from scenario planning to operational action in a single environment, with full transparency at every step.”
At the heart of this alliance is a shared belief that clinical supply planning and execution should live in one connected environment. “Together, Perceptive and Trialzen are working toward a unified way of operating, where strategic decisions and day–to–day execution come together, enabling greater visibility, smarter scenarios, and more confident supply decisions from manufacturing through to patient dosing”. said Tony Street, Senior Vice President Strategy at Trialzen.
Clients benefit from:
Faster study start-up and smoother amendments through early supply optimizationHigher quality supply decisions driven by expert oversight and data backed insightGreater confidence through strategic expert consultancy for complex trialsMid-study forecast adjustments and up-to-date quantitative support for key decisions
About Perceptive eClinical
Perceptive eClinical is a trusted leader in delivering advanced trial capabilities. With over 30 years of proven Interactive Response Technology (IRT) and supply management expertise, more than 500 regulatory approvals and support for three million patients worldwide, we deliver reliability, security and precision. This is reflected in our consistently high customer satisfaction score of 4.5 out of 5 over the past three years. Our future-proof IRT solution, Clinphone Pro, helps sponsors manage the speed, complexity and personalization of modern clinical trials. Built for flexibility and seamless integration, it supports smarter, more efficient studies across all phases and therapeutic areas. In 2025, Perceptive eClinical was recognized as a leader in Everest Group’s PEAK Matrix® Assessment for RTSM Solutions, affirming our commitment to innovation, global delivery excellence and measurable value for sponsors and CROs.
About Trialzen
Trialzen is a technology company built by industry experts specializing in clinical trial supply forecasting and planning. Its Forecast & Planning Solution (FPS) is a purpose-built SaaS platform that enables sponsors and CROs to model, simulate, and optimize clinical supply strategies across the full trial lifecycle. Built by clinical supply experts, Trialzen combines advanced mathematical modelling and analytics with a transparent, user-friendly interface, allowing teams to evaluate scenarios, anticipate risk, and make informed supply decisions with speed and confidence.
Sources
McKinsey & Company, Clinical Supply Chains insights
Media Contact: Zara Broadfield, Marketing Director Perceptive eClinical, zara.broadfield@perceptive.com
Logo – https://mma.prnewswire.com/media/2965426/Perceptive_eClinical.jpg
Logo – https://mma.prnewswire.com/media/2965427/5936695/Trialzen.jpg
View original content:https://www.prnewswire.co.uk/news-releases/perceptive-eclinical-launches-technologyenabled-clinical-supply-consultancy-in-alliance-with-trialzen-302754074.html
Technology
Mouser Electronics New Product Insider: Over 9,000 New Parts Added in First Quarter of 2026
Published
7 minutes agoon
April 27, 2026By
SHANGHAI, April 27, 2026 /PRNewswire/ — As an authorized distributor, Mouser Electronics, Inc. is focused on the rapid introduction of new products and technologies, giving customers an edge and helping speed time to market. Over 1,200 semiconductor and electronic component manufacturer brands count on Mouser to help them introduce their products into the global marketplace. Mouser’s customers can expect 100% certified, genuine products that are fully traceable from each manufacturer.
Last quarter, Mouser launched more than 9,000 part numbers ready for shipment. Some of the products introduced by Mouser from January through March 2026 include:
STMicroelectronics STM32C5 Arm® Cortex®-M33 Microcontrollers
The STM32C5 microcontrollers (MCUs) from STMicroelectronics are specifically designed to boost the performance of billions of tiny smart devices across factories, homes, cities, and infrastructure while meeting stringent cost, size, and power constraints. Based on ST’s proprietary 40 nm manufacturing process, the STM32C5 MCUs can run tasks noticeably faster than many entry-level chips currently in use. This gives products more room to include features such as improved sensing, smoother control, and enhanced user experiences while keeping dynamic power consumption low. The MCUs also integrate security features that help safeguard products against tampering and cyber risks.EDATEC ED-CM0NANO Single-Board Computer
The ED-CM0NANO is a single-board computer (SBC) from EDATEC, based on the Raspberry Pi Compute Module Zero (CM0). The ED-CM0NANO features a quad-core Arm Cortex-A53 processor running at up to 1 GHz, a Broadcom VideoCore-IV graphics processor, and a wide range of connectivity options. Optional Wi-Fi® support with an external antenna enables wireless connectivity, while integrated real-time clock (RTC) and watchdog timer enhance system reliability. These features make the ED-CM0NANO ideal for industrial control systems and Internet of Things (IoT) applications.Sensata Technologies MGD Resonix™ Refrigerant Leak Sensor
The MGD Resonix™ sensor from Sensata delivers high accuracy and fast response times in a compact module that fits into the smallest heating, ventilation, air conditioning (HVAC), and refrigeration equipment. The MGD series offers superior resistance to overexposure and poisoning, as well as to high temperatures (working temperatures up to 105 °C) and humidity. These devices also have a service life of more than 15 years with no need for calibration, making them the ideal leak-detection component for A2L HVAC and refrigeration systems.u-blox ANN-MB3 Triple-Band GNSS Antenna
The ANN-MB3 from u-blox is a best-in-class L1/L2/L5 triple-band RTK real-time kinematic (RTK) solution ideal for the F20 high-precision GNSS. Optimized for seamless integration, the ANN-MB3 antenna delivers exceptional performance with a robust design. The antenna’s compact (62 × 80 × 25.5 mm) form factor and flexible installation options enable the adoption of high-precision positioning technologies across industrial, automotive, and robotics applications.
To see more of the New Product Insider highlights, go to https://info.mouser.com/new_products/.
For more Mouser news and our latest new product introductions, visit https://www.mouser.com/newsroom/.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/mouser-electronics-new-product-insider-over-9-000-new-parts-added-in-first-quarter-of-2026–302754079.html
SOURCE Mouser Electronics
Weibo Corporation to Report First Quarter 2026 Financial Results on May 28, 2026
Perceptive eClinical Launches Technology-Enabled Clinical Supply Consultancy in Alliance with Trialzen
Mouser Electronics New Product Insider: Over 9,000 New Parts Added in First Quarter of 2026
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days agoThailand regulator mulls crypto futures expansion in licensing overhaul
-
Technology4 days agoSBI Life Insurance registers New Business Premium of ₹42,551 crores for the year ended on 31st March, 2026
-
Technology4 days agoCGI renews global SAP S/4HANA operations and SAP BTP operations certifications, reinforcing its consistent, quality delivery at scale
-
Technology5 days agoContractor Commerce launches AI-powered conversational buying experience
-
Technology5 days agoMILLROCK TECHNOLOGY APPOINTS NEIL A. GOLDMAN AS CFO
-
Technology4 days agoRhythMedix Launches Next-Generation RhythmStar® SL Cardiac Monitor
-
Technology4 days agoGreenzie releases 2025 Annual Safety Report, documenting multi-year safety performance at commercial scale
-
Technology5 days agoFINBOA Named Double Finalist for 2026 Banking Tech Awards
